Results 211 to 219 of about 13,220 (219)

Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam

Antimicrobial Agents and Chemotherapy, 2018
Fernando Sanz-García, Sara Hernando-Amado, Jose Luis Martinez   +2 more
exaly  

Ceftazidime–Avibactam Sodium

openaire   +1 more source

Revisiting REVISIT: The Case for Ceftazidime/Avibactam Plus Aztreonam

Clinical Infectious Diseases
Pranita D Tamma, Thomas P Lodise, Maria F Mojica, Federico Perez, Robert A Bonomo   +4 more
openaire   +2 more sources

Giving Aztreonam-Ceftazidime-Avibactam Its Best Chance

Clinical Infectious Diseases
openaire   +2 more sources

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

Clinical Infectious Diseases, 2016
exaly  

Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo

Journal of Antimicrobial Chemotherapy, 2019
exaly  

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor

Clinical Pharmacist, 2017
openaire   +2 more sources

Ceftazidime/Avibactam (Avycaz) -- a new intraveneous antibiotic.

The Medical letter on drugs and therapeutics, 2016
openaire   +1 more source

Aztreonam-ceftazidime-avibactam may not be enough.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Niaz, Banaei, Stanley C, Deresinski
openaire   +1 more source